Abstract
The effects of FK506, a new immunosuppressive agent, on the development of lupus dermatoses were investigated in the autoimmune-prone MRL/Mp-lpr/lpr (MRL/lpr) mouse, which is an animal model for the spontaneous development of skin lesions similar to those of human lupus erythematosus (LE). FK506 reduced the incidence of skin lesions, lupus nephritis, the titre of serum anti-double-stranded DNA antibodies and the massive T cell proliferation. The incidence and magnitude of IgG deposition at the dermoepidermal junction were not changed. These results suggest that FK506 is a promising immunosuppressive agent for the control of autoimmune skin diseases.
Similar content being viewed by others
References
Abu-Elmagd K, Jegasothy BV, Ackerman CD, Thomson AW, Rilo H, Nikolaidis N, Van Thiel D, Fung JJ, Todo S, Starzl TE (1991) Efficacy of FK506 in the treatment of pyoderma gangrenosum. Transplant Proc 23: 3328–3329
Berden JHM, Faaber P, Assmann KJM, Rijke TPM (1986) Effects of cyclosporin A on autoimmune disease in MRL/l and BXSB mice. Scand J Immunol 24: 405–411
Furukawa F, Tanaka H, Sekita K, Nakamura T, Horiguchi Y, Hamashima Y (1984) Dermatopathological studies on skin lesions of MRL mice. Arch Dermatol Res 276: 186–194
Furukawa F, Imamura S (1986) Pathogenesis of lupus dermatoses in autoimmune mice. VIII. Effects of cyclophosphamide and prednisolone on skin lupus band test and related autoimmune traits in New Zealand mice. Acta Dermatol (Kyoto) 81: 53–58
Furukawa F, Taniguchi S, Tachibana T, Horiguchi Y, Kanauchi H, Ohshio G, Hamashima Y, Imamura S (1988) Pathogenesis of lupus dermatoses in autoimmune mice. X. Evaluation of histamine-N-methyltransferase activity in the skin of autoimmune mice. Microbiol Immunol 32: 83–96
Furukawa F, Ohshio G, Imamura S (1993) Pathogenesis of lupus dermatoses in autoimmune mice. XIX. Attempts to induce subepidermal immunoglobulin deposition in MRL/Mp-+/+ mice. Arch Dermatol Res 285: 20–26
Horiguchi Y, Furukawa F, Hamashima Y, Imamura S (1984) Ultrastructural observations of skin lesions in MRL mice — dermoepidermal junction. Arch Dermatol Res 276: 229–234
Horiguchi Y, Furukawa F, Hamashima Y, Imamura S (1986) Ultrastructural lupus band test in the skin of MRL mice. Arch Dermatol Res 278: 474–480
Horiguchi Y, Furukawa F, Imamura S (1986) Ultrastructural observations of skin lesions in MRL mice — dermal infiltrations and capillary changes. J Dermatol 13: 440–447
Jegasothy BV, Ackerman CD, Todo S, Fung JJ, Abu-Elmagd K, Starzl TE (1992) Tacrolimus (FK506) — a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol 128: 781–785
Kanauchi H, Furukawa F, Imamura S (1991) Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions. J Invest Dermatol 96: 478–483
Kanauchi H, Takigawa M, Imamura S, Furukawa F (1994) Effects of cyclosporin A on lupus dermatoses in autoimmune prone MRL/Mp-lpr/lpr mice. J Dermatol Treat 5: 187–191
Kanauchi H, Imamura S, Takigawa M, Furukawa F (1994) Evaluation of the Japanese-Chinese herbal medicine, Kampo for the treatment of lupus dermatoses in autoimmune prone MRL/Mp-lpr/lpr mice. J Dermatol 21: 935–939
Kavai M, Banyai A, Zsindely A, Sonkoly I, Sogedi G (1982) Enzyme-linked immunosorbent assay for antibodies to native DNA in sera of patients with SLE. J Immunol Methods 48: 169–175
Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H (1987) FK506, a novel immunosuppressant isolated from a streptomyces. 1. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 40: 1249–1255
Knight JG, Adams DD, Purves HD (1977) The genetic contribution of the NZB mouse to the renal disease of the NZB x NZW hybrid. Clin Exp Immunol 28: 352–358
Meingassner JG, Stutz A (1992) Immunosuppressive macrolides of the type FK506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 98: 851–855
Mountz JD, Smith HR, Wilder RL, Reeves JP, Steinberg AD (1987) CsA therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. J Immunol 138: 157–163
Murphy ED, Roths JB (1978) Autoimmunity and lymphoproliferation. Induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In: Bigazzi PE, Warner NL (ed) Genetic control of autoimmune disease. Elsevier, New York, pp 207–221
Ohshio G, Furukawa F, Yoshioka H, Taki Y, Manabe T, Ozawa K, Tobe T, Hamashima Y (1987) High levels of antimitochondrial antibodies in MRL mice. Influence of anti-DNA antibodies on anti-mitochondrial antibodies measured by an enzyme-linked immunosorbent assay. Microbiol Immunol 31: 75–81
Paulis A, Stellato C, Cirillo R, Ciccarelli A, Oriente A, Marone G (1992) Anti-inflammatory effect of FK506 on human skin mast cells. J Invest Dermatol 99: 723–728
Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramanan R, Jain A (1989) FK506 for liver, kidney and pancreas transplantation. Lancet II: 1000–1004
Tachibana T, Furukawa F, Taniguchi S, Hamashima Y, Imamura S (1985) Histamine metabolism in skin of MRL/l mice. Arch Dermatol Res 278: 57–60
Takabayashi K, Koike T, Kurasawa K, Matsumura R, Sato T, Tomioka H, Ito I, Yoshiki T, Yoshida S (1989) Effect of FK506, a novel immunosuppressive drug on murine systemic lupus eryfhematosus. Clin Immunol Immunopathol 51: 110–117
Takagishi K, Yamamoto N, Nishimura A, Yamasaki G, Kanazawa N, Hotokebuchi T, Kaibara N (1989) Effects of FK506 on collagen arthritis in mice. Transplant Proc 21: 1053–1055
Thomson AW, Starzl TE (1992) FK506 and autoimmune disease: perspective and prospects. Autoimmunity 12: 303–313
Watanabe-Fukunaga R, Brannan CI, Itoh N (1992) The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148: 1274–1279
White DJG (1991) FK506: the promise and the paradox. Clin Exp Immunol 83: 1–3
Yamamoto K, Mori A, Nakahama T, Ito M, Okudaira H, Miyamoto T (1990) Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK506. Immunology 69: 222–227
Yamamoto S, Jiang H, Kato R (1994) Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent. J Invest Dermatol 102: 160–164
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Furukawa, F., Takigawa, M. & Imamura, S. FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. Arch Dermatol Res 287, 558–563 (1995). https://doi.org/10.1007/BF00374076
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00374076